ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2025

Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease.

J Bradley Layton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.